Download the whole Issue

EDITORIAL P.4

ORIGINAL ARTICLES

Role of ultrasound examination in a complex investigation of a kidney graft function. Sh.R. Galeyev, E.R. Gafourova P.5

Activity indices of the sodium-lithium countertransport and lipid spectrum in teenagers with frequent respiratory diseases. V.N. Oslopov, R.R. Fasakhov, Kh.M. Vakhitov, T.A. Fomicheva, L.F. Vakhitova P.8

Indices of the electric field of the heart in the anterior and anterolateral myocardial infarction on the data of electrocardiotopography. N.A. Andreichev, E.N. Andreicheva, L.V. Baleyeva, P. Swapnil P.11

Changes of the vegetation status in patients with ischemic heart disease after complexial treatment using novocain blockade of artery thorax inter. I.V. Bilalov, R.R. Bilalova P.20

Clinical efficiency of s-amlodipine (escordicor) in elderly patients with hypertonic and ischemic heart diseases. I.A. Latfoullin, Z.F. Kim, R.F. Gaifoullina P.21

Safety and efficacy of carvedilol in the treatment of isolated systolic hypertension in elderly patients. R.R. Fasakhov, R.I. Akhmerova, E.I. Merkoulova, L.D. Akhmetgaliyeva P.24

Patients with chronic obstructive pulmonary disease in real clinical practice. R.F. Khamitov, E.Z. Kоudriyavtseva, E.I. Vankova, Kh.Kh. Khоusainov, A.S. Bоurchagina P.26

FOR GENERAL PRACTITIONER

Realization of «Conception of health protection of healthy people» and «Protection and improvement of health of healthy people in Russian Federation for 2003—2010» applied-research program in clinical hospital of Ministry of Internal Affairs of Tatarstan. I.A. Bourenina P.31

Analysis of the idiopathic pulmonary fibrosis hospital current. K.R. Sоulbayeva, R.F. Khamitov, E.Z. Kоudriyavtseva P.34

Problems of chronic brochopulmonary diseases in adolescents. E.S. Trountsova, G.R. Sagitova, E.A. Khasyanov P.37

JUBILEE

75-anniversary of the department of internal diseases № 2 of Kazan state medical university. R.F. Khamitov, I.A. Latfoullin, G.P. Ishmourzin P.40

REVIEWS

Arterial hypertension and endothelium dysfunction (part II). S.D. Mayanskaya, A.A. Popova, N.N. Mayanskaya, E.N. Berezikova, L.D. Khidirova P.43

The role of nitric oxide in pathology of internal diseases (literature review). R.G. Saifoutdinov P.48

Drug addiction and infectious pathology: clinical and immunological aspects (literature review). R.F. Khamitov, I.G. Moustafin, О.L. Paicova P.54

LECTURES

Iron deficiency and iron deficiency anemia. N.A. Andreichev, L.V. Baleyeva P.60

Medication strategy for supraventricular arrhythmias. I.A. Latfoullin, R.F. Gaifoullina P.65

CLINICAL CASE

The aortic dissection as the possiblе outcome of the uncontrolled arterial hypertension. A.A. Podolskaya, R.I. Akhmerova, E.I. Merkоulova P.70

___

EDITORIAL P.4

ORIGINAL ARTICLES

Role of ultrasound examination in a complex investigation of a kidney graft function

Sh.R. Galeyev, E.R. Gafourova

Abstract. In the article analysis of 872 ultrasound examinations of renal grafts was performed. The diagnostic signifi cance of resistance index defi nition in an estimation of a function state of a grafted kidney on early and in the remote periods of observation is detected.

Key words: kidney transplantation, ultrasound examination.

References

1. Gabriel', M.D. Rukovodstvo po transplantacii pochki / M.D. Gabriel'; per. s angl. pod red. Ja.G. Mojsjuka. — 3-e izd. — Tver': OOO «Izd-vo Triada», 2004. — 472 s.
2. Nazarenko, G.I. Dopplerograficheskie issledovanija v uronefrologii / G.I. Nazarenko, A.N. Hitrova, TV. Kras­nova. — M.: Medicina, 2002. — 152 s.
3. Pilotovich, V.S. Hronicheskaja bolezn' pochek / V.S. Pi-lotovich, O.V. Kalachik. — M.: Med. lit., 2009. — 288 s: il.
4. Sandrikov, V.A. Klinicheskaja fiziologija transplanti­rovannoj pochki / V.A. Sandrikov, V.I. Sadovnikov. — M.: MAIK «Nauka / Interperiodka», 2001. — 288 s: il.

Activity indices of the sodium-lithium countertransport and lipid spectrum in teenagers with frequent respiratory diseases

V.N. Oslopov, R.R. Fasakhov, Kh.M. Vakhitov, T.A. Fomicheva, L.F. Vakhitova

Abstract. 115 children at the age of 15—18 years were examined for the purpose of determined the degree of infl uense of the friquent respiratory desease on the level of the activity of the sodium-lithium countertransport (SLC) end lipid spectrum. Among them 67 children had the friquent relapses of the acute respiratory desease — the 1-st group, 48 — were sick rarely — the 2-d group. Also some indices of the lipidic exchange were analyzed. During the statistical processing the method of the qartile analysis was used. It was established that according to the average the more, high velocityof the (SLC) is peculiar to the children which are in poor health. The maximum importances of all the examined indices, except of the cholesterol and the malonic dialdehyde, happened to the second quartile of the fi rst group; whereas in the second group of the second qartile the more high were the levels of the cholesterol of the lipoproteins of the low and the lowest thickness. On the basis of the preceding we can suppose that the children have the velocity of the SLC which us in the limits of 166-217 mkmol/L/RBC/h. i.e. The children of the second qartile have a greater risk of the development of dislidemios.

Key words: cellular countertransport, children, lipidic exchange.

References

1. Ahmetzjanov, V.F. Sostojanie natrij-litievogo protivo-transporta pri infarkte miokarda: avtoref. dis. … kand. med. nauk / V.F. Ahmetzjanov. — Kazan', 1999. — 20 s.
2. Valeeva, I.H. Biohimicheskie metody issledovanija obshhih mehanizmov povrezhdenija i vozdejstvija ksenobio-tikov / I.H. Valeeva, L.E. Ziganshina. — Kazan': KGMU, 2008. —56 s.
3. Baranov, A.A. Social'nye i organizacionnye problemy pediatrii: izbr. ocherki / A.A. Baranov, V.Ju. Al'bickij. — M.: Izdat. dom «Dinastija», 2003. — 511 s.
4. Oslopov, V.N. Znachenie membrannyh narushenij v razvitii gipertonicheskoj bolezni: avtoref. dis. … d-ra med. nauk / V.N. Oslopov. — Kazan', 1995 — 78 s.
5. Tarasova, I.V. Recidivirujushhaja respiratornaja infekcija u detej i ponjatie «chasto bolejushhie deti» / I.V. Tarasova // Allergologija i immunologija v pediatrii. — 2006. — № 23. — S.34—40.
6. Titov, VN. Klinicheskaja biohimija zhirnyh kislot, lipidov, lipoproteidov / V.N Titov. — M.: OOO «Triada», 2008. — 270 s.
7. Hasanov, N.R. Variabel'nost' ritma serdca i osobennostej vegetativnoj reguljacii u lic s pogranichnoj arterial'noj gipertenziej pri razlichnyh znachenijah skorosti natrij-litievogo protivotransporta v jeritrocitah: avtoref. dis. … kand. med. nauk / N.R. Hasanov. — Kazan', 1996. — 28 s.
8. Hasanova, D.R. Membrannye osnovy sindromov vegetativ-noj disfunkcii: avtoref. dis. … d-ra med. nauk / N.R. Ha-sanov. — Kazan', 1999 — 56 s.
9. Hardman, T.C. Relation of sodium-lithium countertransport activiti to markers of cardiovascular risk in normotensive subjects / T.C. Hardman, S.W. Dubrei, S. Soni // J. Hum. Hipertens. — 1995. — № 9(7). —P.589—596.

Indices of the electric field of the heart in the anterior and anterolateral myocardial infarction on the data of electrocardiotopography

N.A. Andreichev, E.N. Andreicheva, L.V. Baleyeva, P. Swapnil

Abstract. Quantitative and qualitative parameters of the electric fi eld of the heart (EFH) are studied, localizations of the typical changes in the anterior and anterolateral myocardial infarction (MI) are specifi ed on the data of electrocardiotopography (ECTG). ECTG was performed in 78 healthy subjects (control groupp — CG) and 147 patients with MI of different localization on the 3-4 week of disease (9pts with anterior and 20 pts with anterolateral MI among them). The areas of overlapping zones (OZ) in electropositivity (EP) and electronegativity (EN) are reduced due to the direction changes of the vectors of initial and fi nal forces in comparison with CG. Length of the reliable dicreasing of potential and zero zone (ZZ), appearing in EP, is more in anterolateral MI, than in anterior MI. In patients with anterolateral MI the determinant importance of the prevalence of the process has the registration of QS wave in V1 lead. In anterolateral MI with QS in V1 the area of lesion is maximal. In assessment of the length of the process in anterior and anterolateral MI ZZ in EP differs. In anterior MI it spreads more to the upper levels of registration, affecting the posterior part of interventricular septum (IVS) and high posterior-septal area or the high part of IVS ( in the inferior third). In the anterolateral MI it spreads more to the lower levels of registration, involving the inferior-septal and inferior-apical areas. Quantitative indices of EFH in MI of anterior localisations ststistically reliable differ from CG and characterize the prevalence of EN in the second half of the circular dipole motion, especially on the front surface of the torax in the anterior and anterolateral MI and sharp dicreasing EP on the anterior and posterior thoracic surface.

Key words: myocardial infarction, electrocardiotopography, electropositivity, electronegativity, zero zone.

References

1. Amirov, R.Z. Diagnosticheskie vozmozhnosti jelektrokar-diotopografii pri infarkte miokarda / R.Z. Amirov // XII Mezhdunarodnyj kongress po jelektrokardiologii: tez. dokl. — Minsk, 1985. — S.8—9.
2. Andreichev, N.A. Ocenka amplitudno-vremennyh pokazate-lej pri komp'juternom analize mnozhestvennyh otvedenij JeKG pri infarkte miokarda / N.A. Andreichev // Hirurgija ishemicheskih sindromov organov i tkanej: tez. Mezhdunar. konf. — Nizhnekamsk, 1998. — S.49—50.
3. Mirrahimov, M.M. Diagnostika infarkta mezhzheludochkovoj peregorodki serdca metodom integral'noj kardiotopogra-fii / M.M. Mirrahimov, Ju.B. Vimbor, K.K. Kenenbaev // Kardiologija. — 1981. — № 9. — S.52—57.
4. Rjabykina, G.V. Diagnostika ishemicheskoj bolezni serdca po dannym prekordial'nogo kartirovanija / G.V. Rjabykina, M.M. Saltykova, A.V. Sobolev [i dr.] // Kardiologija. — 1989. — № 5. — S.44—48.
5. Shaposhnik, I.I. Sopostavlenie dannyh jelektrokardioto-pografii i morfologicheskogo issledovanija serdca pri infarkte miokarda / I.I. Shaposhnik, P.L. Gladyshev // Kardiologija. — 1986. — № 6. — S.54—57.
6. Andreichev, N.A. Electrocardiotopography value in myocardial infraction and stenocardia / N.A. Andreichev // Abhang lungen der Akademie der Wissenschhaften der DDR. Electrocardiology-87. — Berlin, 1988. — P.473—476.
7. Dambrink, J.-H.E. Assosiation of Left Ventricular Remodeling and Nonuniform Electrical Recovery Expressed by Nondipolar QRST Integral Map Patterns in Survivors of a First Anterior Myocardial Infastion / J.-H.E. Dambrink, A.S. Groenewegen, W.H. van Gilst [et al.] //Circulation. — 1995. — Vol. 92, № 3. — P.300—310.
8. Green, L.S. Clinical Applications of Body Surface Potential Mapping / L.S. Green, J.A. Abildskov // Clinical Cardiology. — 1995. — Vol. 18. — P.245—249.
9. Hayashi, H. Body surface cardiac mapping / H.Hayashi // Nippon Rinsho. — 1997. —Vol. 55, suppl. 1. — P.536—540.
10. Jeremy, R.W. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction / R.W. Jeremy, R.A. Hackworthy, G. Bautovich G. [et al.] // J. Am. Coll. Cardiol. — 1987. — Vol. 9. — P.989—995.
11. Kingma, J.H. Acute intervention with captopril during thrombolysis in patients with fi rst anterior myocardial infarction / J.H. Kingma, W.H. van Gilst, K.H. Peels [et al.] // Eur. Heart. J. — 1994. — Vol. 15. — P.898—907.
12. Kozlikova, K. Electric instability after myocardial infarction displayed in body surface potential maps / K. Kozlikova // J. of Electrocardiology. — 1995. — Vol. 28, № 4. — P.354—355.
13. MacMechan, S.R. Body Surface ECG Potential Maps in Acute Myocardial Infarction / S.R. MacMechan, M.B.G. Mackenzie, J. Allen // J. of Electrocardiology. — 1995. — Vol. 28. — P.184—190.
14. Taccardi, B. Relationships between myocardial activity and potentials on the ventricular surfaces / B. Taccardi, B.B. Punske, R.L. Lux [et al.] // J.of Electrocardiology. — 1998. — Vol. 30. — P.1—4.
15. Watanabe, Y. The State of Body Surface Mapping in Japan / Y. Watanabe // J. of Electrocardiology. — 1995. — Vol. 28. — P.110—120.
16. Yasui, S. Normal body surface maps / S. Yasui, K. Ikeda // Report of Japanese Circulation Society Task Fone Committee on Criteria for Body Surface Mapping. — Suzuken Center Co., Nagoya, Japan, 1991. — P.237—292.
17. Yasui, S. Importance and problems of diagnostic criteria of body surface mapping / S. Yasui, A. Akutsu, A. Suzuki, T. Watanabe // Jpn. J. of Clinical Medicine. — 1995. — Vol. 53, № 1. — P.14—19.

Changes of the vegetation status in patients with ischemic heart disease after complexial treatment using novocain blockade of artery thorax inter

I.V. Bilalov, R.R. Bilalova

Abstract. Investigation about infl uence of Novocain blockade artery thorax inter on the vegetation status of the 42 patients with ischemic heart disease by the results of heart rate variability has been made.

Key words: ischemic heart, vegetation status, Novocain blockade, heart rate variability.

References

1. Baevskij, R.M. Matematicheskij analiz izmenenij ser-dechnogo ritma pri stresse / R.M. Baevskij, O.I. Kirillov, S.Z. Kleckin. — M.: Nauka, 1984. — S.39—93.
2. Baevskij, R.M. Vozrastnye osobennosti serdechnogo ritma u lic s razlichnoj stepen'ju adaptacii k uslovijam okruzhaju-shhej sredy / R.M. Baevskij, A.P. Berseneva, Zh.V. Barsukova // Fiziologija cheloveka. — 1985. — T.11, № 2. — S.208.
3. Buziashvili, Ju.I. Dinamika pokazatelej variabel'nosti ritma u bol'nyh IBS do i posle prjamoj revaskuljari-zacii miokarda / Ju.I. Buziashvili, E.M. Hananashvili, Ju.I.Sigaev [i dr.] // Kardiologija. — 2002. — № 7. — S.12—15.
4. Voronin, I.M. Variabel'nost' serdechnogo ritma vo vremja sna u zdorovyh ljudej / I.M. Voronin, E.V. Birju-kova // Vestnik aritmologii. — 2002. — № 30. — S.68— 71.
5. Smetnev, A.S. Variabel'nost' ritma serdca, zheludoch-kovye aritmii i risk vnezapnoj smerti / A.S. Smetnev, O.I. Zharinov, V.N. Chubuchnyj // Kardiologija. — 1995. — № 4. — S.49—52.
6. Chazov, E.I. Innervacija serdca / E.I. Chazov, V.N. Shvalev // Rukovodstvo po kardiologii. — M.: Medicina, 1982. — T.1. — S.56—59.
7. Bigger, J.T. Variabiliti in healthy, middle-aged persons compared of recent acute myocardial infarction / J.T. Bigger, J.T. Fleiss, R.C. Steinman [et al.] // Circulation. —1995. —Vol. 91. — P.1936—1943.
8. Casolo, G. Twenty-fourhour spectral analysis of heart rate variability in congestive heart failure secondary to coronary artery disease / G. Casolo, E. Balli, A. Fazi [et al.] // Am. J. Cardiol. — 1991. — № 13. — P.1154—1158.
9. Casolo, G. Decreased heart rate variability in congestive heart failure / G. Casolo // Am. J. Cardiol. — 1992. — № 2. — P.286—287.
10. Inazumi, T. Changes in autonomic nervous activity prior to spontantous coronary spasm in patients with variant angina / T. Inazumi, Y. Shimizu [et al.] // Jpn. Circ. J. — 2000. — Vol.64. —P.197—201.
11. Takusagowa, M. Alteration of autonomic fctivity in recurrence of variant angina / M. Takusagowa, S. Komori [et al.] // J. T. F. R. T. — 1999. — Vol.82. — P.75—81.
12. Vanoli, E. Heart rate variability during specifi c sleep stage. A comparison of healthy subjects with patients after myocar-dial infarction / E. Vanoli, B. Adomson [et al.] // Circulation. — 1995. — Vol.91. — P.1918—1922.

Clinical efficiency of s-amlodipine (escordicor) in elderly patients with hypertonic and ischemic heart diseases

I.A. Latfoullin, Z.F. Kim, R.F. Gaifoullina

Abstract. The article presents clinical experience of administration of escordicor and enalapril to elderly patients with hypertonic and ischemic heart diseases demonstrated high hypotension activity and no side effects.

Key words: hypertension disease, treatment, escordicor, enalapril.

References

1. Arsen'eva, K.E. S(-)amlodipin: novye vozmozhnosti far-makoterapii arterial'noj gipertonii / K.E. Arsen'eva // Russkij medicinskij zhurnal. — 2008 — T. 16, № 21. — S.1466—1470.
2. SESA study — Safety and effi cacy of S(-)Amlodipine // JAMA. — 2003. — № 2(8). — R.87—92.
3. Rocha, E. Isolated systolic hypertension—epidemiology and impact in clinical practice / E. Rocha [et al.] // Rev. Port. Car-diol. — 2003. — № 22(l). — R.7—23.
4. Alam, M.G. Systolic blood pressure is the main etiology for poorly controlled hypertension / M.G. Alam // Am. J. Hyper-tens. — 2003. — № 16(2). — R.140—143.
5. Grimm, R.H. Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension / R.H. Grimm [et al.] // Am. J. Hypertens. — 2002. — № 15, rt. 1. — R.31—36.
6. Kannel, W.B. Prevalence and implications of uncontrolled systolic hypertension / W.B. Kannel // Drugs Aging. — 2003. — № 20(4). — R.277—286.
7. Otchet o provedenii klinicheskogo issledovanija, FGU «GNIC PM Roszdrava» pod rukovodstvom akad. RAMN Oga-nova R.G., 2006.

Safety and efficacy of carvedilol in the treatment of isolated systolic hypertension in elderly patients

R.R. Fasakhov, R.I. Akhmerova, E.I. Merkoulova, L.D. Akhmetgaliyeva

Abstract. Treatment of arterial hypertension in elderly patients is important problem today. Safety and effi cacy of carvedilol as monotherapy in the treatment of isolated systolic hypertension in elderly patients are substantiated in article.

Key words: elderly patients, arterial hypertension, carvedilol.

References

1. Shal'nova, S.A. Arterial'naja gipertonija: rasprostra-nennost', osvedomlennost', priem antigipertenzivnyh preparatov i jeffektivnost' lechenija sredi naselenija Rossijskoj Federacii / S.A. Shal'nova, Ju.A. Balanova, V.V. Konstantinov [i dr.] // Rossijskij kardiologicheskij zhurnal. — 2006. — № 4. — S.45—57.
2. Chazova, I.E. Lechenie arterial'noj gipertenzii kak pro-filaktika serdechno-sosudistyh oslozhnenij / I.E. Chazova // Serdechnaja nedostatochnost'. — 2002. — № 1. — S.14—19.
3. Gurevich, M.A. Arterial'naja gipertonija u pozhilyh: ruko-vodstvo dlja vrachej / M.A. Gurevich. — M., 2004. — 144 s.
4. Kobalava, Zh.D. Arterial'naja gipertonija: novoe v dia-gnostike i lechenii / Zh.D. Kobalava, Ju.V. Kotovskaja. — M.: Optima, 2006. — 368 s.
5. Rekomendacii-2007 po lecheniju arterial'noj gipertonii. Rabochaja gruppa po lecheniju arterial'noj gipertonii Evropejskogo obshhestva po arterial'noj gipertonii i Evropejskogo obshhestva kardiologov // Racional'naja farmakoterapija v kardiologii. — 2008. — № 1/2. — 76 s. (Pril.).

Patients with chronic obstructive pulmonary disease in real clinical practice

R.F. Khamitov, E.Z. Kоudriyavtseva, E.I. Vankova, Kh.Kh. Khоusainov, A.S. Bоurchagina

Abstract. This study was carried out with the purpose of researching the features of clinic and treatment of patients with COPD and a long-term estimation of inclusion tiotropium in a medical complex. Potential possibilities of infl uence on disease appearance by strengthening measures on smoking cessation and improvement of a medical complex are revealed. Proof positive infl uence of tiotropium on COPD features as a reduction of dyspnea, cough, and sputum expectorance, improvements of the general state of health, increase FEV1 and tolerance to physical activity.

Key words: chronic obstructive pulmonary disease, clinical and history features, treatment, Spiriva.

References

1. Hronicheskaja obstruktivnaja bolezn' legkih: klinicheskie rekomendacii / pod red. A.G. Chuchalina. — M.: Izd-vo «At-mosfera», 2003. — 168 s.
2. Kunicyna, Ju.L. Protivovospalitel'naja terapija bol'nyh pri hronicheskoj obstruktivnoj bolezni legkih / Ju.L. Ku-nicyna, E.I. Shmelev // Pul'monologija. — 2003. — № 2. — S.111—116.
3. Lopez, A.D. The global burden of disease, 1990—2020 / A.D. Lopez, C.C.J.L. Murray // Nat. Med. — 1998. — № 4. — R.1241—1243.
4. National Heart, Lung, and Blood Institute/World Health Organi¬zation. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO work¬shop report. Available at: http://www.goldcopd.com
5. Rudolf, M. The reality of drug use in COPD: the European perspective / M. Rudolf // Chest. — 2000. — Vol.117(suppl). — P.29—32.
6. Warne, P.J. COPD: Market Opportunities for New Therapies and Diagnostics / P.J. Warne. — Richmond, Surrey, UK: PJB Publications Ltd, 2000. — S.1085.
7. World Health Organization. World health report 2000. Health systems: improving performance. Annex table 3. Available at: http://www.who.int/whr/2000/index.htm. Accessed January 11, 2002.

FOR GENERAL PRACTITIONER

Realization of «Conception of health protection of healthy people» and «Protection and improvement of health of healthy people in Russian Federation for 2003—2010» applied-research program in clinical hospital of Ministry of Internal Affairs of Tatarstan

I.A. Bourenina

Abstract. In order to realize the «Conception of health protection of healthy people» and «Protection and improvement of health of healthy people in Russian Federation for 2003—2010» applied-research program a medical rehabilitation unit has been organized in the clinical hospital of the Ministry of the Interior of Tatarstan. The organization of the medical rehabilitation unit will allow solving the problem of medical rehabilitation of not only internal affairs offi cers but of pensioners, veterans and disabled persons worked for the Ministry of the Interior as well as of their family members who need preventive treatment every year.

Key words: medical rehabilitation, aftertreatment, health of healthy people, post-traumatic stress-induced disorders, mental desadaptation, individual rehabilitation program.

References

1. Agapova, M.V. Social'no-psihologicheskie aspekty soci-al'nogo vygoranija i samoaktualizacija lichnosti: avtoref. dis. … kand. psihol. nauk / M.V. Agapova. — Jaroslavl', 2004.
2. Bobrovnickij, I.P. Vosstanovitel'naja medicina, reabili-tacija i vosstanovitel'noe lechenie: ponjatija i organizacija dejatel'nosti v sisteme zdravoohranenija Rossijskoj Fede-racii / I.P. Bobrovnickij // Vosstanovitel'naja medicina i reabilitacija. — M., 2005. — S.14—15.
3. Bobrovnickij, I.P. Metodologicheskie osnovy razrabotki tehnologij ocenki i korrekcii funkcional'nyh rezervov v sfere vosstanovitel'noj mediciny i kurortologii / I.P. Bobrovnickij // Aktual'nye problemy vosstanovi-tel'noj mediciny, kurortologii i fizioterapii. — M., 2006. — S.16—19.
4. Bogoljubov, V.M. Medicinskaja reabilitacija ili vossta-novitel'naja medicina? / V.M. Bogoljubov // Fizioterapija, bal'neologija i reabilitacija. — 2006. — № 1. — S.3— 12.
5. Vodop'janova, N.E. Sindrom vygoranija: diagnostika i pro-filaktika / N.E. Vodop'janova, E.S. Starchenkova. — SPb.: Piter, 2005. — 336 s.: il.
6. Grachev, S.G. Osobennosti social'no-psihologicheskij de-formacii lichnosti sotrudnikov organov vnutrennih del, prinimavshih uchastie v kontrterroristicheskoj operacii na territorii Severo-Kavkazskogo regiona / S.G. Grachev //
7. Voprosy psihologii jekstremal'nyh situacij. — 2006. — № 4. — S.25—29.
8. Dudko, T.N. Differencirovannaja sistema reabilitacii v narkologii: metodicheskie rekomendacii. / T.N. Dudko, V.A. Puzienko, L.A. Kotel'nikova. — M., 2001. — 38 s.
9. Kolos, I.V. K voprosu o prichinah i uslovijah sovershenija suicidal'nyh dejstvij sotrudnikami organov vnutrennih del / I.V. Kolos // Voprosy ukreplenija socialisticheskoj zakonnosti v dejatel'nosti organov vnutrennih del: sb. — M., 1989. — S.25—30.
10. Profilaktika samoubijstv sotrudnikov organov vnutren-nih del: metod. rekomendacii / pod obshh. red. M.I. Mar'i-na. — M., 1999.
11. Mar'in, M.I. Psihologicheskoe obespechenie operativno-sluzhebnoj dejatel'nosti OVD i rabota s kadrami / M.I. Ma-r'in, Ju.G. Kasperovich // Psihopedagogika v pravoohrani-tel'nyh organah. —2006. — № 1 (25). — S.3—8.
12. Mar'in, M.I. Profilaktika professional'noj deforma-cii lichnosti sotrudnika organov vnutrennih del: metod. posobie / M.I. Mar'in, A.V. Budanov, V.E. Petrov [ i dr.]. — M.: IMC GUK MVD Rossii, 2004. — S.70.
13. Organizacija vneplanovyh medicinskih i psihodiagno-sticheskih osmotrov (obsledovanij) sotrudnikov organov vnutrennih del Rossijskoj Federacii, prinimajushhih uchastie v vypolnenii operativno-sluzhebnyh, sluzhebno-boevyh i inyh zadach, soprjazhennyh s opasnost'ju dlja zhizni i prichineniju vreda zdorov'ju v osobyh uslovijah: metod. posobie / Ministerstvo vnutrennih del Rossijskoj Federacii, departament tyla; sost.: N.I. Mjagkih, A.I. Er-machkov, A.I. Adaev, A.V. Kaljaev, E.L. Usol'ceva. — M., 2007. — 38 s.
14. Ocenka adaptacionnyh vozmozhnostej organizma i pro-blemy vosstanovitel'noj mediciny / R.M. Baevskij, A.L. Syrkin, A.D. Ibatov, A.V. Sobolev, A.G. Chernikov // Vestnik vosstanovitel'noj mediciny. — 2004. — № 2. — S.19.
15. Pazhil'cev, I.V. Psihologicheskie osobennosti lichnosti sotrudnikov specpodrazdelenij MVD Rossii — uchastni-kov kontrterroristicheskoj operacii na Severnom Kavkaze i ih psihoterapevticheskaja korrekcija: avtoref. dis. ... kand. psihol. nauk / I.V. Pazhil'cev. — SPb., 2007. — 20 s.
16. Programma psihologicheskoj pomoshhi sotrudnikam i vo-ennosluzhashhim, osushhestvljajushhim kontrterroristicheskie meroprijatija v Severo-Kavkazskom regione / MVD RF. Glav-noe upravlenie kadrov. Medicinskoe upravlenie. — M., 2001.
17. Profilaktika professional'noj deformacii lichnosti sotrudnika organov vnutrennih del: metod. posobie / pod obshh. red. V.M. Burykina. — M.: IMC GUK MVD Rossii, 2004. — 144 s.
18. Putin, V.V. Vstupitel'noe slovo na zasedanii Prezidiuma Gosudarstvennogo soveta / V.V. Putin // Kurortnye vedomo-sti. — 2004. —№ 6(27). — S.2—3.
19. Razumov, A.N. Vosstanovitel'naja medicina: rol' i mesto v sovremennoj medicinskoj nauke i sisteme zdravooh-ranenija / A.N. Razumov, I.P. Bobrovnickij // Kurortnye vedomosti. — 2002. — № 4 (13). — S.2—7.
20. Razumov, A.N. Razvitie koncepcii vosstanovitel'noj me-diciny kak profilakticheskogo napravlenija medicinskoj nauki i prakticheskogo zdravoohranenija / A.N. Razumov, I.P. Bobrovnickij // Problemy sovershenstvovanija me-dicinskogo obrazovanija i vosstanovitel'nogo lechenija rasprostranennyh zabolevanij. — Stavropol'; Esentuki, 2006. — S.69—89.
21. Rukovodstvo po reabilitacii lic, podvegshihsja stressor-nym nagruzkam. —M.: Medicina, 2004. — 400 s.
22. Sazonova, L.A. Reabilitacija i vosstanovitel'naja tera-pija uchastnikov vooruzhennyh konfliktov / L.A. Sazonova, S.V. Arsent'eva // Psihopedagogika v pravoohranitel'nyh organah. — 2002. — № 2.

Analysis of the idiopathic pulmonary fibrosis hospital current

K.R. Sоulbayeva, R.F. Khamitov, E.Z. Kоudriyavtseva

Abstract. This study was carried out with the purpose of researching the features of clinic and treatment of hospitalized patients with idiopathic pulmonary fi brosis (IPF). It has been revealed that more heavier current of IPF with requirement of hospitalization is characterized for senior ages regardless of a gender. The current of IPF was complicated by accompanying pulmonary pathology, fi rst of all chronic obstructive pulmonary disease. It was increasing the volume and cost of the treatment. Patients had low necessity in the antibiotic therapy (28% of patients), but all of them took glucocorticosteroids (100% of patients). The most dynamic indicators against a background of this treatment were a dyspnea, a body temperature and level of leucocytosis.

Key words: idiopathic pulmonary fi brosis, clinical symptoms, treatment.

References

1. Avdeev, S.N. Idiopaticheskij fibrozirujushhij al'veolit / S.N. Avdeev, O.E. Avdeeva, A.G. Chuchalin // Russkij medi-cinskij zhurnal. — 1998. — T. 6, № 4.
2. Vinogradova, D.N. Idiopaticheskij fibrozirujushhij al'-veolit: vozmozhnosti komp'juternoj tomografii v pervich-nom raspoznavanii i utochnenii stadii patologicheskogo processa / D.N. Vinogradova, V.I. Amosov, M.M. Il'-kovich // Pul'monologija. — 2000. — № 16. — S.36—37, 41.
3. Dmitrieva, L.I. Principy luchevoj diagnostiki in-tersticial'nyh zabolevanij legkih / L.I. Dmitrieva, E.I. Shmelev, I.Je. Stepanjan, A.T. Sigaev // Pul'monolo-gija. — 2002. — № 4. — S.11—17.
4. Intersticial'nye zabolevanija legkih: rukovodstvo dlja vrachej / pod red. M.M. Il'kovicha. — M.: Izd-vo «Intan», 2005. — S.127—183.
5. Chuchalin, A.G. Idiopaticheskij legochnyj fibroz / A.G. Chu-chalin // Terapevticheskij arhiv. — 2000. — № 3. — S.5— 12.
6. Bittmann, I. Stem cells and repair of lung injuries / I. Bittmann, T. Dose, G. Baretton [et al.] //Am. J. Clin. Pathol. — 2001. — Vol. 115 (4). — P.525—533.
7. Colby, T.V. Pathological approach to idiopathic interstitial pneumonias: useful points for clinicians / T.V. Colby // Breath. —2004. — Vol. 1(1). — P.43—49.
8. Hamman, L. Acute diffuse interstitial fi brosis of the lung / L. Hamman, A. Rich // Bull. Johns. Hopk. Hosp. —1944. — Vol. 74. — P.176—206.
9. Quanjer, Ph.H. Standardized lung function testing / Ph.H. Quanjer // Offi cial Statement of the European Respiratory Society. — Luxembourg, 1993. — P.5—40.
10. Scadding, J.G. Fibrosing alveolitis / J.G.Scadding // BMJ. —1964. — Vol. II. — P.686.
11. World Health Organization. World health report 2000. Health systems: improving performance. Annex table 3. Available at: http://www.who.int/whr/2000/index.htm. Accessed January 11,

Problems of chronic brochopulmonary diseases in adolescents

E.S. Trountsova, G.R. Sagitova, E.A. Khasyanov

Abstract. Chronic and recurrent bronchopulmonary pathology consistently ranked third in the structure of adolescent morbidity and often leads them to a disability. The main purpose of the study was to evaluate the prevalence of chronic bronchopulmonary diseases among adolescents. To achieve this goal, an epidemiological study was conducted among 328 adolescents from 15 to 18 years living in the city of Astrakhan, a random sample using a special questionnaire. It was found that 11.6% adolescents had chronic bronchopulmonary diseases, and among them the proportion of persons with asthma — more than 70%. The prevalence of asthma and other chronic bronchopulmonary diseases of nontuberculous etiology of adolescent Astrakhan, determined with the help of epidemiological research and the questionnaire several times higher than offi cial statistics.

Key words: chronic bronchopulmonary diseases, adolescents.

References

1. Rozinova, N.N. Vozrastnaja jevoljucija hronicheskih zabole-vanij legkih: deti, podrostki, vzroslye / N.N. Rozinova,     5. M.N. Kovalevskaja, E.I. Shmelev, P.P. Zaharov // Pul'mo-nologija detskogo vozrasta: problemy i reshenija / pod red. Ju.L. Mizernickogo, A.D. Caregorodceva. —M., 2003. — Vyp. 3. —S.111—113.
2. Kaganov, S.Ju. Sovremennye bolezni legkih v svete mezhdunarodnoj statisticheskoj klassifikacii boleznej     6. H peresmotra / S.Ju. Kaganov, N.N. Rozinova, A.E. Bogorad // Pul'monologija detskogo vozrasta: problemy i reshenija / pod red. Ju.L. Mizernickogo, A.D. Caregorodceva. — M., 2002. — Vyp. 2. —S.11—15.
3. Knjazheskaja, N.P. Diagnostika, nabljudenie i vedenie podrostkov s bronhial'noj astmoj / N.P. Knjazheskaja // Pul'monologija detskogo vozrasta: problemy i reshenija / pod red. Ju.L. Mizernickogo, A.D. Caregorodceva. — M., 2003. — Vyp. 3. — S.107—108.
4. Geppe, N.A. Novaja rabochaja klassifikacija bronholegochnyh zabolevanij u detej / N.A. Geppe, N.N. Rozinova, I.K. Vol-kov, Ju.L. Mizernickij // Doktor Ru. —2009. —№ 1. — S.7—13.
5. Goloborod'ko, M.M. Jepidemiologicheskie aspekty boleznej melkih bronhov na primere Sankt-Peterburga / M.M. Go-loborod'ko, A.V. Bogdanova, N.E. Arestova, E.V. Bojcova // Oblastnaja detskaja klinicheskaja bol'nica: kliniko-diagnosticheskie i organizacionnye problemy: sb. nauch. tr. / pod red. V.I. Purin'. —SPb., 2008. — T. 4. — S.432—436. Peroni, D. Asthma in children / D. Peroni, G. Piacentini, A. Sab-bion, A. Boner // European Respiratory Monograph Asthma. — 2003. — Vol.8, № 23. — P.278—292.

ЮБИЛЕИ

75-anniversary of the department of internal diseases № 2 of Kazan state medical university

R.F. Khamitov, I.A. Latfoullin, G.P. Ishmourzin

Abstract. Article is dedicated to the history of the department of internal diseases №2 from the moment of her creation to the present. Are represented all chairman of department , basic directions of medical and scientifi c work.

Key words: the department of internal diseases, chairman of department.

References

1. Anisimov, V.E. Professor Z.I. Malkin / V.E. Anisimov, F.T. Krasnoperov. — Kazan': Tatar. kn. izd-vo, 1987. —88 s.
2. Anisimov, V.E. Professor M.N. Cheboksarov / V.E. Anisi-mov. — Kazan': Tatar. kn. izd-vo, 1970. — 87 s.
3. Al'bickij, V.Ju. Istorija Kazanskogo gosudarstvennogo medicinskogo universiteta / V.Ju. Al'bickij, N.H. Amirov, A.S. Sozinov, A.B. Galljamov. — Kazan': Magarif, 2006. — 374 s.
4. Kazanskij medicinskij institut (1814—1989): v 2 ch. / Istorija razvitija nauchnyh shkol. — Kazan': Izd-vo Kazan. un-ta, 1989. — Ch. I. — 303 s.
5. Kazanskij medicinskij institut (1814—1989): v 2 ch. / Osnovnye napravlenija issledovanij i razvitija nauchnyh shkol na sovremennom jetape. Kazan': Izd-vo Kazan. un-ta, 1989. — Ch. II. — 157 s.

REVIEWS

Arterial hypertension and endothelium dysfunction (part II)

S.D. Mayanskaya, A.A. Popova, N.N. Mayanskaya, E.N. Berezikova, L.D. Khidirova

Abstract. It is presented the literature review about modern endotheliology. The role of endothelium in regulation of vascular tonus; the mechanism of endothelium dysfunction formation; NO-dependent mechanisms of hupertension; the meaning of free-radical oxidation and antioxydant protection system in development of endothelial dysfunction and arterial hypertension are described.

Key words: review, arterial hypertension, endothelial dysfunction, nitric oxide, system of pro- and antioxydant activity renin-angiotensin system.

References

1. Almazov, V.A. Arterial'naja gipertenzija i pochki / V.A. Al-mazov, E.V. Shljahto. — SPb.: Izd-vo SPbGMU, 1999. — S.46—61.
2. Babak, O.Ja., Shaposhnikova Ju.N., Nemcova V.D. // Ukrainskij terapevticheskij zhurnal. — 2004. — № 1. — S.14—21.
3. Ivleva, A.Ja. Klinicheskoe primenenie ingibitorov angio-tenzin prevrashhajushhego fermenta i antagonistov angio-tenzina II / A.Ja. Ivleva. — M., 1998. — 158 s.
4. Kutyrina, I.M. Pochki i arterial'naja gipertenzija // Nefrologija (rukovodstvo dlja vrachej) / I.M. Kutyrina, A.A. Mihajlov; pod red. I.E. Tareevoj. — M.: Medicina, 2000. — S.164—187.
5. Ljamina, N.P. Sutochnaja produkcija NO u bol'nyh arteri-al'noj gipertoniej II stadii / N.P. Ljamina, V.N. Senchihin, P.V. Dolotovskaja [i dr.] // Ros. kard. zhurn. — 2001. — № 6 (32). — S.34—37.
6. Mazo, E.B. Diagnosticheskoe znachenie opredelenija prosta-glandinov u bol'nyh nefrogennoj arterial'noj giperten-ziej / E.B. Mazo, V.Ja. Kakitelashvili [i dr.] // Urologija i nefrologija. — 1991. — № 4. — S.21—24.
7. Manuhina, E.B. Rol' oksida azota i kislorodnyh svobod-nyh radikalov v patogeneze arterial'noj gipertenzii / E.B. Manuhina, N.P. Ljamina, P.V. Dolotovskaja [i dr.] // Kardiologija. — 2002. — № 11. — S.73—84.
8. Manuhina, E.B. Deponirovanie oksida azota v serdechno-sosudistoj sisteme / E.B. Manuhina, B.V. Smirin, I.Ju Ma-lyshev // Izvestija RAN. — 2002. — № 3. — S. 43—45. — (Serija «Biologija»).
9. Mareev, V.Ju. Chetvert' veka jery ingibitorov APF v kardio-logii / V.Ju. Mareev // Ros. med. zhurn. — 2000. — № 8. — S.15—16; 602—609.
10. Markov, H.M. Molekuljarnye mehanizmy disfunkcii sosu-distogo jendotelija / H.M. Markov // Kardiologija. — 2005. — № 12. — S.62—67.
11. Mashina, S.Ju. Rol' preduprezhdenija deficita oksida azota v antigipertenzivnom jeffekte adaptacii k gipok-sii / S.Ju. Mashina, B.V. Smirin, D.A. Pokidyshev [i dr.]. // Izvestija RAN. — 2001. — № 5. — S.579—587. — (Serija «Biologija»).
12. Preobrazhenskij, D.V. Ingibitory APF i AT1-blokatory v klinicheskoj praktike: monografija / D.V. Preob-razhenskij, B.A. Sidorenko, T.A. Batyraliev. — M., 2002. —Ch. 1. — 224 s.
13. Abe, J.-I. Reactive oxygen species of signal transduction in cardiovascular disease / J.-I., Abe, C. Berk // Trends. Cardiovasc. Med. — 1998. — Vol. 8, № 59. — P.64.
14. Abrahamsson, T. Vascular bound recombinant extracellular superoxide dismutase type C protect against the detrimental effects of superoxide radicals on endothelium — dependent arterial relaxation / T. Abrahamsson, U. Brandt, S.L. Marklund [et al.] // Circular. Res. — 1992. — Vol. 70. — P.264—271.
15. Alonso, J. Endothelial cytosolic proteins bind to the 3’ un­translated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor alfha / J. Alonso, M.L. San­chez, M. Montyn [et al.] // Mol. Cell. Biol. — 1997. — Vol. 17, № 10. — P.5719—5726.
16. Cannon, R.O. Role of nitric oxide in cardiovascular disease: focus on the endothelium / R.O. Cannon // Clin. Chem. — 1998. — № 44. — P. 1809—1819.
17. Cardillo, C. Selective defect in nitric oxide synthesis may ex­plain the impaired endothelium — dependent vasodilatation in patients with essential hypertension / C. Cardillo, C.M. Kilcoyne, A.A. Quyyumi [et al.] // Circulation. — 1998. — Vol. 97. № 9. — P.851—856.
18. Chatziantoniou, C. Nitric oxide inhibition and early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice / C. Chatziantoniou, J. Boffa, R. Ardaillou, J. Dussaule // J. Clin. Invest. — 1998. — Vol. 101. — P.2780— 2789.
19. Chou, T.C. Alterations of nitric oxide synthesis with aging and hypertension in rats / T.C. Chou, M.H. Yen, Y.A. Ding // Hypertension. — 1998. — № 31. — P.643—648.
20. Cohen, R.A. The role of nitric oxide and other endothelium — derived vasoactive substances in vascular disease / R.A. Cohen // Progr. Cardio-vasc. Dis. — 1995. — № 38. — P.105—128.
21. Cosentino, F. Role of superoxide anions in the mediation of endothelium — dependent contractions / F. Cosentino, J.C. Sill, Z.S. Katusic // Hypertension. — 1994. — № 23. P.229—235.
22. Cowley, A.W. The role of the kidney in hypertension / A.W. Cowley, R.J. Roman // JAMA. — 1996. — Vol. 275. — P.1581—1589.
23. De Keulener, G.W. Tumor necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle /
24. G.W. de Keulener, R.W. Alexander, M. Ushio-Fukai // Biochem. J. — 1998. — Vol. 329. — P.653—657.
25. Drexler, H. Nitric oxide and coronary endothelial dysfunction in humans / H. Drexler // Rewiew Cardiovasc. Res. — 1999. — № 43 (3). — P.572—579.
26. Feliciano, L. Coronary artery blood flow: physiologic and pathophysiologic regulation / L. Feliciano, R.J. Henning // Clin. Cardiol. — 1999. — № 2. — P.775—786.
27. Gabbai, F.B. Effects of nitric oxide synthase blockers on renal function / F.B. Gabbai // Nephrol. Dial. Transplant. — 2001. — Vol. 16, № 1. — P.10 — 13.
28. Gerova, M. Nitric oxide compromised hypertension: facts and enigmas / M. Gerova // Physiol. Res. — 2000. — № 49. — P.27—35.
29. Gilbert, M.T. Mechanisms for the coordinated synthesis and secretion of rennin / M.T. Gilbert, J. Sun // Am. J. Hypertension. — 1995. — № 8. — P.50A (Abstract).
30. Griendling, K.K. NADH/NADPH oxidase and vascular function / K.K. Griendling, M. Ushio-Fukai // Trends Cardiovasc. Med. — 1997. — № 7. — P.301—307.
31. Grunfeld, S. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats / S. Grunfeld, C.A. Hamilton, S. Mesaros [et al.] // Hypertension. — 1995. — № 26. — P.854—857.
32. Hall, J.E. Role of the rennin — angiotensin system in control of sodium excretion and arterial pressure / J.E. Hall, A.C. Guyton, H.L. Mizelle // Acta Physiol. Scand. — 1990. — Vol. 139, № 591. — P.48—62.
33. Hayakawa, H. The link among nitric oxide synthase activity, endothelial function and aortic and ventricular hypertrophy in hypertension / H. Hayakawa, L. Raij // Hypertension. — 1997. — № 29. — P.235—241.
34. Kanner, J. Nitric oxide as an antioxidant / J. Kanner, S. Harel, R. Granit // Arch. Biochem. Biophys. — 1991. — Vol. 289. — P.130—136.
35. Kerr, S. Superoxide anion production is increased in a model of genetic hypertension. Role of endothelium / S. Kerr, J. Bronsan, M. McIntyre // Hypertension. — 1999. — Vol. 33. — P.1353— 1358.
36. Klahr, S. The role of nitric oxide in hypertension and renal disease progression / S. Klahr // Nephrol. Dial. Transplant. — 2001. — Vol. 16, № 1. — P.60—62.
37. Konishi, M. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries / M. Konishi, C. Su // Hypertension. — 1983. — № 5. — P.881—886.
38. Lefevre, G. Evaluation of lipid peroxidation by measuring thio-barbituric acid reactive substances / G. Lefevre G., M. Beljean-Leymarie, F. Beyerle [et al.] // Ann. Biol. Clin. (Paris). — 1998. — № 56 (3). — P.305—319.
39. Lew, R. The distribution of beta-adrenoreceptors in dog kidney: an autoradiographic analysis / R. Lew, R.J. Summers // Fur. J. Pharmacol. — 1987. — Vol. 140. — P.1—11.
40. Lind, L. Endothelium — dependent vasodilatation in hypertension: a review / L. Lind, S.-O. Granstam, J. Millgard // Blood Pressure. — 2000. — № 9. — P.4—15.
41. Mancini, G.B.J. Angiotensin-converting enzyme inhibition with quinalapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND study / G.B.J. Mancini, G.C. Henry, C. Macaya [et al.] // Circulation. — 1996. — Vol. 94.— P.258—265.
42. McIntyre, M. Endothelial function in hypertension. The role of superoxide anion / M. McIntyre, D.F. Bohr, A.F. Dominiczal // Hypertension. — 1999. — Vol. 34. — P.539—545.
43. Mendes Ribeiro, A.C. Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure / A.C. Mendes Ribeiro, T.M. Brunini, J.C. Ellory, G.E. Mann // Cardiovasc. Res. — 2001. — Vol. 49. — P.697—712.
44. Newaz, M.A. Alpha-tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats / M.A. Newaz, N.N. Nawal, C.H. Rohaizan [et al.] // Am. J. Hypertens. — 1999. — № 12. — P.839—844.
45. Pagano, P.J. Superoxide anion production by the thoracic aorta: Effect of endothelium — derived nitric oxide / P.J. Pagano, K. Tornheim, R.A. Cohen // Am. J. Physiol. — 1993. — Vol. 265. — P.707—712.
46. Puig, J.G. Uric acid as a cardiovascular risk factor in arterial hypertension / J.G. Puig, L.M. Ruillope // J. Hypertens. — 1999. — № 17. — P.869—872.
47. Rajagopalan, S. Angiotensin II — mediated hypertension in the rat increases vascular superoxide production via memrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone / S. Rajagopalan, S. Kurz, T. Munzel [et al.] // J. Clin. Invest. — 1996. — Vol. 97. — P.1916—1923.
48. Rao, G.N. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression / G.N. Rao, B.C. Berk // Circulat. Res. — 1992. — Vol. 70. — P.593—599.
49. Robertson, J.I.S. Cardiac failure, the kidney, renin and atrial peptides / J.I.S. Robertson, A.M. Richards // Europ. Heart. J. — 1988. — № 9. — P.11—14.
50. Romero, J.C. Role of angiotensin and oxidative stress in essential hypertension / J.C. Romero, J.F. Reckelhoff // Hypertension. — 1999. — Vol. 34. — P.943—949.
51. Sealey, J.E. Evidence for cardiovascular effect of prorenin / J.E. Sealey // J. Human Hypertens. — 1995. — № 9. — P.381—384.
52. Singh, R.B. Effect of hydrosoluble coenzyme Q10 on blood pressure and insulin resistance in hypertensive patients with coronary artery disease / R.B. Singh, M.A. Niaz, S.S. Rastogi [et al.] // J. Hum. Hypertens. — 1999. — № 13. — P.203—208.
53. Soloviev, A.I. Evidence for the involvement of protein kinase C in depression of endothelium — dependent vascular responses in spontaneously hypertensive rats / A.I. Soloviev, A.V. Parshikov, A.V. Stefanov // Vasc. Res. — 1998. — Vol. 35. — P.325—331.
54. Sundaresan, M. Requirement for generation of H2O2 for PDGF signal transduction / M. Sundaresan, Z.X. Yu, V.I. Ferrans [et al.] // Science. — 1995. — Vol. 270. — P.296—299.
55. Tolins, J.P. Role of endothelium — derived relaxing factor in hemodynamic response to acetylcholine in vivo / J.P. Tolins,
56. © R.G.Sajfutdinov, 2009
57. R. Raij // In: Nitric oxide from L-arginin: a bioregulatory system. Royal Society (London). — 1989. — № 13.
58. Touyz, R.M. Oxidative stress and vascular damage in hypertension / R.M. Touyz // Curr. Hypertens. Rep. — 2000. — № 2. — P.98—105.
59. Touyz, R.M. Ang II-stimulated superoxide production is mediated via phospholipase D in himan vascular smooth muscle cell / R.M. Touyz, E.L. Schiffrin // Hypertension. — 1999. — Vol. 34. — P.976—982.
60. Wagner, G. Control of the renal rennin system by local factors / G. Wagner, B.L. Jensen, B.K. Kramer [et al.] // Kidney Int. — 1998. — Vol. 54, № 67. — P.78—83.
61. Wang, X. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B recep­tor mRNA after angioplasty — induced neoinyimal formation in the rat / X. Wang, S. Douglas, C. Louden [et al.] // Circulat. Res. — 1996. — Vol. 78. — P.322—328.
62. Wattanpitayakul, S.K. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin — induced cardiovascular disorders / S.K. Wattanpitayakul, D.M. Weinstein, B.J. Holycross, J.A. Bauer // FASEB J. — 2000. — № 14 (2). — P.271—278.
63. Wei, E.P. Superoxide generation and reversal of acetylcholin-induced cerebral dilatation after acute hypertension / E.P. Wei, H.A. Kontos, C.W. Christman // Circulat. Res. — 1985. — Vol. 57. — P.781—787.
64. Zafari, A.M. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy / F.M. Zafari, M. Ushio-Fukai [et al.] // Hypertension. — 1998. — Vol. 32. — P.488—495.
65. Zatz, R. Chronic nitric oxide inhibition model six years on / R. Zatz, C. Baylis // Hypertension. — 1998. — Vol. 32. — P.958—964.

The role of nitric oxide in pathology of internal diseases (literature review)

R.G.Saifoutdinov

Kazan State Medical Academy, Department of Therapy № 1

Key words: nitric oxide, pathology of internal organs.

References

1. Bondar', I.A. Oksid azota i diabeticheskie angiopatii / T.A. Bondar', V.V. Klimontov, I.A. Porshennikov // Sahar-nyj diabet. — 1999. — № 4. — S.1—3.
2. Vanin A.F. Oksid azota v biologii: istorija, sostojanie i perspektivy issledovanij / A.F. Vanin // Biohimija. — 1998. — Vyp. 7. — S.867—869.
3. Vink, D.A. Znachenie himicheskih svojstv oksida azota dlja lechenija onkologicheskih zabolevanij / D.A. Vink, J. Vodo-voz, Dzh.A. Kuk [i dr.] // Biohimija. — 1998. — Vyp. 7. — S.948—957.
4. Vinogradov, N.A. Mnogolikaja okis' azota / N.A. Vinogra-dov // Rossijskij zhurnal gastrojentorologii, gepatologii, koloproktologii. — 1997. —№ 2. — S.6—11.
5. Golikov, P.P. Harakter vzaimosvjazi oksida azota s an-giotenzinprevrashhajushhim fermentom i malonovym dial'-degidom u bol'nyh s aterogennym stenozom vnutrennej sonnoj arterii / P.P. Golikov, V.L. Lemenev,V.V. Ahmetov // Klinichemkaja medicina. — 2004. — № 7. — S.15—19.
6. Gorren, A.K.F. Universal'naja i kompleksnaja jenzimologija sintazy oksida azota / A.K.F. Gorren, B. Majer // Biohi-mija. — 1998. — Vyp. 7. — S.870—880.
7. Drapkina, O.M. Osobennosti sinteza oksida azota u bol'nyh infarktom miokarda / O.M. Drapkina, O.O. Zado-rozhnaja, V.T. Ivashkin [i dr.]// Klinicheskaja medicina. — 2000. — № 3. — S.19—23.
8. Zvenigorodskaja, L.A. Oksid azota kak marker vospalenija pri steatogepatite u bol'nyh s metabolicheskim sindromom / L.A. Zvenigorodskaja, T.V. Nilova // Ros. medicinskij zhurnal. — 2008. —T. 10, № 2. — S.41—47.
9. Korobejnikova, Je.M. Ocenka sostojanija nitroksidergiche-skoj vazorelaksacii po soderzhaniju nitratov v syvorotke krovi bol'nyh IBS / Je.M. Korobejnikova, Ju.V. Kudrevich // Klinicheskaja laboratornaja diagnostika. — 2001. — № 10. — S.2—3.
10. Kos'micki, M. Nitraty pri lechenii koronarnoj bolezni / M. Kos'micki, Z. Sadovski // Novosti farmacii i medici-ny. — 1996. —T. 30, № 2—3 (156). — S.54—60.
11. Lazebnik, L.B. Rol ' NO v jetiopatogeneze nekotoryh zabole-vanij organov pishhevarenija / L.B. Lazebnik, V.N. Drozdov, E.N. Baryshnikov // Jeksperimental'naja i klinicheskaja gastrojenterologija. — 2005. — № 2. —S.4—11.
12. L'vov, N.P. Molibden v assimiljacii azota u rastenij i mikroorganizmov / N.P. L'vov. — M., 1989. — 87 s.
13. Malyshev, I.Ju. Vvedenie v biohimiju oksida azota. Rol' oksida azota v reguljacii osnovnyh sistem organizma / I.Ju. Malyshev // Rossijskij zhurnal gastrojenterologii, gepatologii, koloproktologii. — 1997. — № 1. — S.49— 55.
14. Manuhina. E.B. Zashhitnye i povrezhdajushhie jeffekty pe-riodicheskoj gipoksii: Rol' oksida azota / E.B. Manuhina, H.F. Dauni, R.T. Mallet, I.Ju. Malyshev // Vestnik Ros. AMN. — 2007. — № 2. — S.25—33.
15. Metel'skaja V.A. Skrinning-metod opredelenija urovnja metabolitov oksida azota v syvorotke krovi / V.A. Me-tel'skaja, N.G. Tumanova // Klinicheskaja laboratornaja dia-gnostika. — 2005. — № 6. — S.15—18.
16. Pulatova, M.K. Jelektronnyj paramagnitnyj rezonans v molekuljarnoj radiobiologii / M.K. Pulatova, G.T. Rihi-reva, Z.V. Kuropteva. — M., 1989. — 232 s.
17. Reutov, V.P. Ciklicheskie prevrashhenija oksida azota v organizme mlekopitajushhih / V.P. Reutov, U.G. Sorokina, V.E. Ohotin, N.S. Kosicyn. — M., 1998. — 231 s.
18. Sajfutdinov, R.G. Paramagnitnye centry biologicheskih zhidkostej cheloveka i ih diagnosticheskaja i patogenetiche-skaja rol' pri nekotoryh zabolevanijah vnutrennih orga-nov: dis. … dokt. med. nauk / R.G. Sajfutdinov. — Irkutsk, 1989. — 437 s.
19. Sajfutdinov, R.G. Dinamika NVS sljuny / R.G. Sajfutdi-nov, A.V. Suhanov // Plenum NOG Rossii. — Rostov n/D., 1995. — S.52—53.
20. Severina, I.S. Rastvorimaja guanilatciklaza v moleku-ljarnom mehanizme fiziologicheskih jeffektov oksida azota / I.S. Severina // Biohimija. — 1998. — Vyp. 7. — S.939—947.
21. Sedov, K.R. Metod jelektronnogo paramagnitnogo rezonansa v klinike vnutrennih zabolevanij / K.R. Sedov, R. G. Sajfut-dinov. — Irkutsk, 1993. — 156 s.
22. Stokle, Zh.K. Giperprodukcija oksida azota v patofizio-logii krovenosnyh sosudov / Zh.K. Stokle, R. Andrianci-tohajna, A.L. Kleshhev // Biohimija. — 1998. — Vyp. 7. — S.976—983.
23. Titov, V.N. Oksid azota v reakcii jendotelijzavisimoj vazodilatacii. Osnovy edinenija jendotelija i gladkomy-shechnyh kletok v parakrinnoj reguljacii metabolizma / V.N. Titov // Klinicheskaja laboratornaja diagnostika. — 2007. — № 2. — S.23—39.
24. Tjejlor, B.S. Inducibel'naja sintaza oksida azota v pecheni: reguljacija i funkcii / B.S. Tjejlor, L.H. Alarson, T.R. Bil-liar // Biohimija. — 1998. — Vyp. 7. — S.905—923.
25. Shubin, V.E. Issledovanie metodom JePR obrazovanija okisi azota pri vosstanovlenii nitrofuranov i nit-roimidazolov. I. Rastvory gemoglobina / V.E. Shubin, Z.V. Kuropteva // Studia biophysica. —1983. —Vol. 97, № 2. —P.157—164.
26. Anderson, R.A. Nitric oxide-dependent human acrosomal loss induced by PPCM (SAMMA) and by nitric oxide donors occurs by independent pathways: basis for synthesis of an improved contraceptive microbicide / R.A. Anderson, K.A. Feathergill, S. Jain, A. Krunic // J. Androl. — 2009. — Vol. 30. — P.168— 182.
27. Anggard, E. Nitric oxide: mediator, murderer, and medicine / E. Anggard // Lancet. — 1994. — Vol. 343. — P.1199—206.
28. Fitzsimmons, R.J. A pulsing electric fi eld (PEF) increases human chondrocyte proliferation through a transduction pathway involving nitric oxide signaling / R.J. Fitzsimmons, S.L. Gordon, J. Kronberg [et al.] // J. Orthop. Res. — 2008. — Vol. 26. — P.854—859.
29. Garaliene, V. Endothelium and nitric oxide / V. Garaliene // Medicina. — 2008. — Vol. 44. — P.564—569.
30. Grasemann, C. Effect of growth hormone therapy on nitric oxide formation in cystic fi brosis patients / C. Grasemann, F. Ratjen, D. Schnabel [et al.] // Eur. Respir J. — 2008. — Vol. 31. — P.815—821.
31. Huang, J. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite / J. Huang, S.C. Lin, A. Nadershahi, S.W. Watts, R. Sarkar // J. Vasc. Surg. — 2008. — Vol. 47. —P.599—607.
32. Karpuzoglu, E. Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: implications for immunity, autoimmune diseases, and apoptosis / E. Karpuzoglu, S.A. Ahmed // Nitric Oxide. — 2006. — Vol. 15. — P.177—86.
33. Koskela, L.R. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis / L.R. Koskela, T. Thiel, I. Ehrjn [et al.] // J. Urol. — 2008. — Vol. 180. — P.737—741.
34. Kugiyama, K. Nitric oxide activity is defi cient in spasm arteries of patients with coronary spastic angina / K. Kugiyama, H. Yasue, K. Okumura // Circulation. — 1996. — Vol. 94. — P.266—272.
35. Mathru, M. Inhaled nitric oxide attenuates reperfusion infl ammatory responses in humans / M. Mathru, R. Huda, D.R. Solanki [et al.] // Anesthesiology. — 2007. — Vol. 106. — P.275—282.
36. Mishra, O.P. Nitric oxide-mediated mechanism of neuronal nitric oxide synthase and inducible nitric oxide synthase expression during hypoxia in the cerebral cortex of newborn piglets / O.P. Mishra, R. Mishra, Q.M. Ashraf, M. Delivoria-Papadopoulos // Neuroscience. — 2006. — Vol. 140. — P.857—863.
37. Nagasaka, Y. Brief periods of nitric oxide inhalation protect against myocardial ischemia-reperfusion injury / Y. Nagasaka, B.O. Fernandez, M.F. Garcia-Saura [et al.] // Anesthesiology. — 2008. — Vol. 109. — P.675—682.
38. Palmer, R.M.J. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor / R.M.J. Palmer, A.G. Ferrige, S. Moncada // Nature. — 1987. — Vol. 327. — P.524—526.
39. Pronai, L. Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies / L. Pronai, K. Ichimori, H. Nozaki [et al.] // Eur. J. Biochem. — 1991. — Vol. 202. — P.923—930.
40. Ouyang, J. A novel fl uorescent probe for the detection of nitric oxide in vitro and in vivo / J. Ouyang, H. Hong, C. Shen [et al.] // Free Radic. Biol. Med. — 2008. –Vol. 45. — P.1426—1436.
41. Rao, D.N. Reductive metabolism of nitroprusside in rat hepatocytes and human erythrocytes / D.N. Rao, S. Elguindi, H.J. O'Brien // Arch. Biochem. Biophys. — 1991. — Vol. 286. — P.30—37.
42. Rakshit, S. N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide / S. Rakshit, J. Bagchi, L. Mandal [et al.] // Apoptosis. — 2009. — Vol. 14. — P.298— 308.
43. Roccatello, D. Isosorbide 5 mononitrate administration increases nitric oxide blood levels and reduces proteinuria in IgA glomerulonephritis patients with abnormal urinary endothelin/ cyclic GMP ratio / D. Roccatello, G. Mengozzi, M. Ferro [et al.] // Clin. Nephrol. — 1995. — Vol. 44. — P.163—169.
44. Saifutdinov, R.G. Methaemoglobin and Hem-NO of the intestinal content investigated by the method of ESR at the patients with the peritonitis / R.G. Saifutdinov, L.A. Sadochina, E.G. Grigorjev // The 2nd Asia-Pacifi c EPR/ESR Symposium Hangzhou. — China, 1999. — P.59.
45. Saifutdinov, R.G. Participation of same bacteria of human intestianal microfl ora in the formation of nitric oxide haemoglobine in vitro / R.G. Saifutdinov, A.V. Sukhanov, K.V. Protasov // 2nd International Conference on Bioradicals and 5th International Workshop on ESR (EPR) Imaging and in vivo ESR Spectroscopy. —Yamagata (Japan), 1997. — P.56.
46. Saifutdinov, R.G. Electron Pfrfmagnetic Resonance in Biochem¬istry and Medicine / R.G. Saifutdinov, L.I. Larina, T.I. Vakulskaya, M.G. Voronkov. — New York, 2000. — 268 s.
47. Schmidt, H.H.H.W. The role of nitric oxide in physiology and pathophysiology / H.H.H.W. Schmidt, H. Hofmann, P. Ogilvie. — Springer, 1995. — P.75—86.
48. Tayeh, M.A. Nitric oxide from L-argenine: A bioregulatory system / M.A. Tayeh, M.A. Marletta // Exerpta medica. — 1990. — P.183—188.
49. Turner, S. Exhaled nitric oxide in the diagnosis and management of asthma / S. Turner // Curr. Opin. Allergy. Clin. Immunol. — 2008. — Vol. 8. — P.70—76.
50. Zweier, J.L. Enzyme-independent formation of nitric oxide in biological tissues / J.L. Zweier, P. Wang, A. Samouilov, P. Kuppusamy // Nat. Med. — 1995. — Vol. 1. — P.804—809.

Drug addiction and infectious pathology: clinical and immunological aspects (literature review)

R.F. Khamitov, I.G. Moustafin, О.L. Paicova

Abstract. Drug addiction is a severe medical and social problem today. The viral hepatitis, HIV, infective endocarditis and pneumonia are the most actual infectious pathology of drug addicts. The diseases of these patients have their own clinical and immunological features. The further researches to optimization of well-timed diagnostics and adequate therapy of an infectious pathology are actual for drug addicts.

Key words: drug addiction, viral hepatitis, HIV, pneumonia.

References

1. Akperov, Je.K. Sostojanie faktorov nespecificheskoj immu-nologicheskoj rezistentnosti u lic, upotrebljajushhih opij i geroin: avtoref. dis. … kand. med. nauk / Je.K. Akperov. — SPb., 2005. — 20 s.
2. Bashirova, D.K. Vlijanie stazha narkomanii na techenie i prognoz VICh-infekcii / D.K. Bashirova, V.R. Habirova, I.M. Haertynova // Kazan. med. zhurnal. — 2004. — T. 85, № 3. — S.177—179.
3. Bogomolov, D.V. O celesoobraznosti vydelenija ponjatija otechnoj fibrinozno-gemorragicheskoj pnevmonii pri narkomanii / D.V. Bogomolov // Al'manah sudebnoj medi-ciny. — 2001. — № 1. — S.24—27.
4. Vitkovskij, Ju.A. Sostojanie immuniteta i limfocitarno-trombocitarnoj adgezii pri pnevmonii / Ju.A. Vitkovskij, Ju.V. Golodnyh, B.I. Kuznik [i dr.] // Terapevticheskij ar-hiv. — 2009. — № 3. — S.40—43.
5. Vyrupaev, K.V. Osobennosti immuniteta i gemostaza u bol'nyh opijnoj narkomaniej: avtoref. dis. … kand. med. nauk / K.V. Vyrupaev. — Chita, 2000. — 27 s.
6. Gamaleja, N.B. Osobennosti gumoral'nogo immuniteta u bol'nyh narkomanijami / N.B. Gamaleja // Voprosy narko-logii. — 1990. — № 2. — S.15—19.
7. Zhestkov, A.V. Opyt lechenija bronholegochnoj patologii u bol'nyh s narkoticheskoj i alkogol'noj zavisimost'ju v Samare / A.V. Zhestkov // Diagnostika i lechenie bronho-legochnoj patologii u bol'nyh s narkoticheskoj i alkogol'-noj zavisimost'ju. — Cheljabinsk, 2008. —(Jelektronnoe izdanie OOO Izdat. dom «MedMatriks»).
8. Zhestkov, A.V. Pnevmonii pri vtorichnyh immunodefi-citnyh sostojanijah: osobennosti gumoral'nyh faktorov / A.V. Zhestkov, M.S. Ustinov, I.Ju. Gemeljuk [ i dr.] // Vestnik SamGU. — 2005. — № 3(37). — S.196—199. —(Estestvenno-nauchnaja serija).
9. Ivashkin, V.T. Osobennosti immunnogo otveta u bol'-nyh hronicheskim virusnym gepatitom S / V.T. Ivashkin, S.N. Mammaev, E.A. Lukina [ i dr.] // Ros. zhurnal gastrojente-rologii, gepatologii, koloproktologii. — 2001. — № 3. — S.24—29.
10. Ignatova, G.L. Klinicheskaja kartina i osobennosti bronho-legochnoj patologii u bol'nyh s narkoticheskoj i alkogol'-noj zavisimost'ju / G.L. Ignatova // Diagnostika i lechenie bronholegochnoj patologii u bol'nyh s narkoticheskoj i alkogol'noj zavisimost'ju. — Cheljabinsk, 2008. — (Jelek-tronnoe izdanie OOO Izdat. dom «MedMatriks»).
11. Immunonarkologija / pod red. V.N. Cygana, P.D. Shabano-va. — SPb.: VMedA, 2008. — 224 s.
12. Kozhevnikova, G.M. Virusnye gepatity u narkomanov / G.M. Kozhevnikova, N.D. Jushhuk // Lechashhij vrach. — 1998. — № 4. — S.32—36.
13. Medicinskaja mikrobiologija / gl. red. V.I. Pokrovskij, O.K. Pozdeev.—M.: GJeOTAR-Medicina, 1999. — S.232—236.
14. Mendelevich, V.D. Narkomanija i narkologija v Rossii v zer-kale obshhestvennogo mnenija i professional'nogo analiza / V.D. Mendelevich. — Kazan': Medicina, 2006. — 260 s.
15. Morfologicheskaja diagnostika narkoticheskih intoksikacij v sudebnoj medicine / pod red. Ju.I. Pigolkina. — M., 2004. — 156 s.
16. Nikolaevskij, E.N. Sovremennye aspekty kliniko-morfologicheskoj kartiny ostrogo i podostrogo infek-cionnogo jendokardita / E.N. Nikolaevskij, G.G. Hubulava, G.H. Avram [ i dr.] // Klinicheskaja medicina. — 2007. — T.85, № 4. — S.27—30.
17. Ostashevskaja, N.G. K voprosu o visceral'noj patologii pri narkomanii kustarnymi preparatami opija / N.G. Osta-shevskaja, A.A. Nadtochij // Alkogolizm i nealkogol'nye tok-sikomanii. Narkomanii i toksikomanii. Respublikanskij sbornik nauchnyh trudov / pod red. I.N. Pjatnickoj. — M.: 2-j MOLGMI im. I.N. Pirogova, 1987. — S.94—97.
18. Pigolkin, Ju.I. Osobennosti morfologicheskih izmenenij v legkih pri hronicheskoj narkomanii / Ju.I. Pigolkin, A.B. Gasanov // Sudebno-medicinskaja jekspertiza. — T.49, № 4. — S.6—10.
19. Pokrovskij, V.V. VICh-infekcija: klinika, diagnostika, le-chenie / V.V. Pokrovskij, T.N. Ermak, V.V. Beljaeva [i dr.] — M.: GJeOTAR-Medicina, 2000. — 489 s.
20. Pjatnickaja, I.N. Narkomanii / I.N. Pjatnickaja. —M.: Me-dicina, 1994. — 541 s.
21. Rahmanova, A.G. Infekcionnye bolezni: rukovodstvo dlja vrachej obshhej praktiki / A.G. Rahmanova, V.A. Neverov, V.N. Prigozhina. — SPb.: Piter, 2001. — 569 s.
22. Risberg, V.Ju. Osobennosti immunnogo statusa i apoptoz limfocitov pri opijnoj narkomanii: avtoref. dis. … kand. med. nauk / V.Ju. Risberg. — Ufa, 2002. — 27 s.
23. Rohlina, M.L. Kliniko-social'nye posledstvija narko-manii / M.L. Rohlina, A.A. Kozlov, I.Ja. Katan // Voprosy narkologii. — 1998. — № 1. — S.11—20.
24. Rohlina, M.L. Narkomanii. Medicinskie i social'nye posledstvija. Lechenie / M.L. Rohlina, A.A. Kozlov. —M.: Izd-vo «Anaharsis», 2001. — 208 s.
25. Selvin, P. VICh i potrebiteli narkotikov — osobaja klini-cheskaja kartina: per. s angl. / P. Selvin. — www.afew.org
26. Selimova, L.M. Jeffekt geroinsoderzhashhih substancij na infekcionnuju aktivnost' virusa immunodeficita chelo-veka tipa 1 in vitro / L.M. Selimova, T.A. Hanina, E.I. Ka-zennova [i dr.] // Voprosy virusologii. — 2002. — T.47, № 5. — S.16—20.
27. Selimova, L.M. Jeffekt dejstvija narkotikov na infek-cionnuju aktivnost' HIV-1 / L.M. Selimova, T.A. Hanina, S.I. Sergeev [ i dr.] // Voprosy virusologii. — 2003. — T.48, № 6. — S.21—25.
28. Fazul'zjanova, A.I. Kliniko-diagnosticheskie osoben-nosti parenteral'nyh i virusnyh gepatitov u bol'nyh s narkoticheskoj intoksikaciej i korrekcija vyjavlennyh narushenij ksimedonom: avtoref. dis. … kand. med. nauk / A.I. Fazul'zjanova. — Ufa, 2002. — 27 s.
29. Chujkova, K.I. Parenteral'nye virusnye gepatity v Tomske / K.I. Chujkova, O.G. Skripnik, T.A. Kovaleva // Jepidemiologija i infekcionnye bolezni. — 2004. — № 3. — S.8—10.
30. Shabanov, P.D. Narkologija: prakticheskoe rukovodstvo dlja vrachej / P.D. Shabanov. — M.: Gjeotar-Med, 2003. — 560 s.
31. Shilova, E.V. Lechenie septicheskoj pnevmonii na fone angiogennogo sepsisa, associirovannogo s parenteral'noj narkomaniej / E.V. Shilova, T.I. Martynenko // Problemy klinicheskoj mediciny. — 2005. — № 2. — S.54—60.
32. Jeris, S.F. VICh-infekcija i zabolevanija dyhatel'nyh putej: per. s angl. / S.F. Jeris, B. Shaf. — www.eurasiahealth.org
33. Alonzo, N.C. Opioids, immunology, and host defenses of intravenous drug abusers / N.C. Alonzo, B.M. Bayer // Infect. Dis. Clin. North Amer. — 2002. — Vol.131, № 3. — P.345— 356.
34. Bhat, R.S. Morphine-induced macrophage apoptosis: Oxidative stress and strategies for modulation / R.S. Bhat, M. Bhaskaran, A. Mongia [et al.] // J. Leukoc. Biol. — 2004. — Vol.75, №6. — P.1131—1138.
35. Biagini, R.E. Immunologic analyses of peripheral leukocytes from workers at an ethical narcotics manufacturing facility / R.E. Biagini, G.M. Henningsen, S.L. Klincewicz // Arch. Environ. Health. — 1995. — Vol.50, № 1. — P.7—12.
36. Blahoutova, V. Opioids and their immunomodulatory properties / V. Blahoutova, A. Zajicova, H. Wilczek, V. Holan // Sas. Lek. Sesk. — 2003. — Vol.142/ — P.244—247.
37. Carr, D.J. Exogenous and endogenous opioids as biological response modifi ers / D.J. Carr, M. Serou // Immunopharmocolo-gy. — 1995. — Vol.31, №1. — P.59—71.
38. Cordero, E. Community-acquired bacterial pneumonia in human immunode-fi ciency virus-infected patients: validation of severity criteria / E. Cordero, J. Pachon, A. Rivero [et al.] // Am. J. Respir. Crit. Care Med. — 2000. — Vol.162. — P.2063—2068.
39. Eisenstein, T.K. Opioid modulation of immune responses: Effects on phagocyte and lymphoid cell populations / T.K. Eisenstein, M.E. Hilburger // J. Neuroimmunol. — 1998. — Vol.83, № 1/2. — P.36—44.
40. Flores, L.R. Mechanisms of morphine-induced immu-nosuppression: Effect of acute morphine administration on lymphocyte traffi cking / L.R. Flores, S.M. Wahl, B.M. Bayer // J. Pharmacol. Exper. Ther. — 1995. — Vol.272, №3. — P.1246—1251.
41. Luza, J. Effect of morphine on phagocytic activity of the poly-morphonuclears and monocytes / J. Luza // Acta Univ. Palacki Olomuc Fac. Med. — 1992. — Vol.134. — R.47—50.
42. Menzerbach, A. Morphine inhibits complement receptor ex­pression, phagocytosis and oxidative burst by a nitric oxide dependent mechanism / A. Menzerbach, J. Hirsch, R. Nast [et al.] // Anasthesiol. Intensivmed. Noftallmed. Schmerzther. — 2004. — Vol.4. — P.204—211.
43. Miller, R. Community acquired lobar pneumonia in patients with HIV-infection and AIDS / R. Miller, N. Foley, D. Kessei [et al.] // Thorax. — 1994. — Vol.49. — P.367—368.
44. Nunez, G. Opioids and immune system / G. Nunez, J. Urana // Rev. Med. Chil. — 1999. — Vol.127, №3. — P.341—348.
45. Ocasio, F.M. Chronic morphine accelerated the progression of lipopolysacharide-induced sepsis to septic shock / F.M. Ocasio, Y. Jiang, S.D. Nouse [et al.] // J. Neuroimmunol. — 2004. — Vol.149, № 1/2. — P.90—100.
46. Osmond, D. Impact of bacterial pneumonia and Pneumocystis carinii pneumonia on human immunodefi ciency virus disease progression / D. Osmond, D. Chin, J. Glassroth [et al.] // Clin. Infect. Dis. — 1999. — Vol.29. — P.536—543.
47. Rogers, T.J. Bidirectional heterologous desensitization of opioid and chemokine receptors / T.J. Rogers, A.D. Steele, O.M. Howard [et al.] // Ann. N. Y. Acad. Sci. — 2000. — Vol.917. — P.19—28.
48. Rouveix, B. Opiates and immune function. Consequences on infections diseases with special reference to AIDS / B. Rouveix // Therapie. — 1992. — Vol.47, № 6. — P.503—512.
49. Saurer, T.B. Morphine-induced alterations of immune status are blocked by the dophamine De-like receptor agonist 7-OH-DPAT / T.B. Saurer, K.A. Carrigan, S.G. Ijames [et al.] // J. Neuroim-munol. — 2004. — Vol.148, № 1/2. — P.54—62.
50. Weber, P.L. Immune, neuroendocrine and somatic alterations in animal models of heroin abuse / P.L. Weber, R. Gomez-Flores, J.E. Smith [et al.] // J. Neuroimmunol. — 2004. — Vol.147, № 1/2. — P.134—137.

LECTURES

Iron deficiency and iron deficiency anemia

N.A. Andreichev, L.V. Baleyeva

Abstract. Prevalence of iron defi ciency, physiologic role of iron in the organism, modern laboratory markers of iron kinetics, biochemical markers of iron defi ciency, classifi cation and clinical picture of iron defi ciency anemia, instrumental diagnostics, management of anemia according to severity and optimal schemes of prophylaxis are described in the article. Effi cacy and safety of different iron-contenting preparations, ways of their intake are shown. Control of МСН, MCV, МСНС is necessary for assessment of effi cacy of treatment. Normalization of those parameters refl ects the adequate therapy.

Key words: iron defi ciency anemia, iron defi ciency, transferrin, ferrum of plasma, iron-contenting preparations.

References

1. Beloshevskij, V.A. Anemii / V.A. Beloshevskij, Je.V. Mina-kov. — Voronezh: Izd-vo im. E.A. Bolhovitinova, 2003. — 346 s.
2. Bokarev, I.N. Anemicheskij sindrom / I.N. Bokarev, E.N. Nemchinov, T.B. Kondrat'eva. — M.: Prakticheskaja medicina, 2006. — 128 s.
3. Vorob'ev, P.A. Anemicheskij sindrom v klinicheskoj prak-tike / P.A. Vorob'ev. — M.: N'judiamed, 2001. — 168 s.
4. Dvoreckij, L.I. Klinicheskie rekomendacii po lecheniju bol'nyh zhelezodeficitnoj anemiej / L.I. Dvoreckij. — Rus. med. zhurnal. — 2004. — № 14. — S.893—897.
5. Demidova, A.V. Anemii / A.V. Demidova. — M.: MEDpress-inform, 2006. — 64 s.
6. Okorokov, A.N. Diagnostika boleznej vnutrennih organov. Diagnostika boleznej sistemy krovi / A.N. Okorokov. — M.: Med. lit., 2001. —T. 4. — 512 s.: il.
7. Okorokov, A.N. Lechenie boleznej vnutrennih organov: prakt. rukovodstvo: v 3 t. / A.N. Okorokov. — Minsk: Vysh. shk.; Vi-tebsk: Belmedkniga, 1998. —T. 3, kn. 2. — 480 s.: il.
8. Protokol vedenija bol'nyh s diagnozom «zhelezodeficit-naja anemija» — M.: N'judiamed, 2005. — 76 s.
9. Rossijskij terapevticheskij spravochnik / pod red. A.G. Chu-chalina. — M.: GJeOTAR- Media, 2007. — 880 s.
10. Rukovodstvo po vnutrennim boleznjam / pod red. Tinsli R. Harrison. — 2003. — T. 1., ch. 6, razd. 2.
11. Rukovodstvo po gematologii: v 3 t. / pod red. A.I. Vo-rob'eva. —3-e izd., pererab. i dop. — M.: N'judiamed, 2002—2004.
12. Rukovodstvo k prakticheskim zanjatijam po fakul'tetskoj terapii / pod red. I.G. Fominoj. — M.: Littera, 2006. — 528 s.
13. Jacobs, P. Erythrocytes: Better Tolerance of Iron Polymaltose Complex Compared with Ferrous Sulphate in the Treatment of Anaemia / P. Jacobs, L. Wood, A.R. Bird // Hematology. — 2000. — № 5(1). — P.77—83.
14. Guralnik, J.M. The prevalence of anemia in persons age 65 and older in the United States: evidence for a high rate of unexplained anemia / J.M. Guralnik, R.S. Eisenstaedt, L. Ferrucci // Blood. — 2004. — Vol. 104. — P.2263—1168.
15. Recommendations to prevent and control iron defi ciency with of the International Nutritional Anemia Consultative Group (INACG), WHO and UNICEF. — Geneve, 2004. — 88 r.

Medication strategy for supraventricular arrhythmias

I.A. Latfoullin, R.F. Gaifoullina

Abstract. The article reviews several forms of supraventricular arrhythmia which complicates the course of coronary heart diseases and current therapy strategies in pre hospital and hospital phases.

Key words: supraventricular arrhythmias, treatment.

References

1. Aronson, F. Nagljadnaja kardiologija / F. Aronson, Dzh. Vard, G. Viner; per. s angl. S.L. Dzemeshkevich. — M.: GJeOTAR-Media, 2005. — 120 s.
2. Zahar, A. Klinicheskaja jeffektivnost' i bezopasnost' kupirovanija paroksizmov fibrilljacii predserdij propa-fenonom / A. Zahar, I.V. Antonchenkov, E.V. Borisova [ i dr.] // Rossijskij kardiologicheskij zhurnal — 2003. —№ 49. — S.59—62.
3. Kardiologija / pod red. B. Griffina, Je. Topolja; per s angl. — M.: Praktika, 2008. — S.429—498.
4. Latfullin, I.A. Klinicheskaja aritmologija / I.A. Latful-lin [i dr.]. — 2002. — S.1—20.
5. Oganov, R.G. Depressivnye rasstrojstva v obshhemedicin-skoj praktike po dannym issledovanija KOMPAS: vzgljad kardiologa / R.G. Oganov, G.V. Pogosova, S.A. Shal'nova [ i dr.] // Kardiologija. — 2005. — № 8. — S.38—44.
6. Pogosova, G.V. Sovremennye podhody k diagnostike i lecheniju rasstrojstv depressivnogo spektra v obshheme-dicinskoj praktike: metod. posobie dlja vrachej / G.V. Po-gosova. — M., 2007.
7. Sulimov, V.S. Narushenie ritma i provodimosti serdca / V.S. Sulimov // Serdce. — 2005. — № 1. — S.31—36.
8. Fomina, I.G. Mercatel'naja aritmija. Sovremennoe sostoja-nie problemy / I.G. Fomina, A.V. Vetluzhskij // Praktikuju-shhij vrach. —2003. — № 2. — S.31—40.
9. Chazov, E.I. Kliniko-jepidemiologicheskaja programma izuche-nija depressii v kardiologicheskoj praktike: u bol'nyh arterial'noj gipertoniej i ishemicheskoj bolezn'ju serdca (KOORDINATA): rezul'taty mnogocentrovogo issledovanija / E.I. Chazov, G.V. Pogosova, S.A. Shal'nova [i dr.] // Kardio-logija. — 2005. — № 11. — S.4—11.
10. Shevchenko, N.M. Kardiologija / N.M. Shevchenko. — M., 2004. —540 s.
11. Buxton, A.E. Multicenter Unsustained Tachycardia Trial Investigators (MUSTT): Electrofhysiologic testing to identify patients with coronary artery desease who are at risk for sudden death / A.E. Buxton, K.L. Lee, L. DiCarlo [et al.] // New Engl. J. Med. — 2000. — Vol. 342. — P.1937.
12. ACC/AHA/ESC Guidelines for the management of patients with atrial fi brillation // Eur. Heart J. — 2001. — P.22 (20).
13. Barry, M. Nadzheludochkovye aritmii / M. Barry, D.O. Wen-berger, M.D. Marinchak // Diagnostika i lechenie v kardiolo-gii / pod red. M.X. Krouforda; per. c angl. — M.: MEDpress-inform, 2007. — S.345—382.
14. Fuster, V. ACC/AHA/ESC guidelines for the management of patients with atrial fi brillation: A repot of the American Colledge Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Commit­tee for Practice Guidelines and Policy Conference / V. Fuster, L.E. Ryden, R.W. Asinger [et al.] // J. Am. Coll. Cardiol. — 2001. — № 38. — 1266 p.
15. Akhtar, M.D. Zheludochkovaja tahikardija / M.D. Akhtar // Diagnostika i lechenie v kardiologii / pod red. M.X. Krou-forda; per s angl. — M.: MEDpress-inform, 2007. — S.432—446.
16. Melvin, M. Fibrilljacija predserdij / M. Melvin, M.D. Schein-man // Diagnostika i lechenie v kardiologii / pod red. M.X. Krouforda; per s angl. — M.: MEDpress-inform, 2007. — S.383—392.
17. Chakko, S. Aritmii i narushenie provodimosti / S. Chakko, R.J. Myerburg // Klinicheskaja kardiologija; per. s angl. — 2-e izd., pererab. — M.; SPb.: Binom-Nevskij dialekt. — 2002. — S.39—87.

CLINICAL CASE

The aortic dissection as the possiblе outcome of the uncontrolled arterial hypertension

A.A. Podolskaya, R.I. Akhmerova, E.I. Merkоulova

Abstract. Тhe article represents clinical case and opportunity of modern diagnosation of the aortic dissection and its branches of the patient with the uncontrolled of the arterial hypertension.

Key words: aortic dissection, arterial hypertension, diagnosation.

References

1. Belov, Ju.V. Klinicheskie maski rasslaivajushhih anevrizm aorty V-tipa / Ju.V. Belov, R.N. Komarov // Angiologija i sosudistaja hirurgija. — 2007. — T. 13, № 3. — S.11—17.
2. Vertkin, A.L. Rassloenie i razryv anevrizmy aorty / A.L. Vertkin, A.A. Vrazovskij, M.I. Lukashov, S.Ju. Chudakov // Cosilium Medicum. — 2007. — T. 5, № 1. — S.13—16.
3. Razumova, E.T. Rassloenie aorty / E.T. Razumova, V.A. Lju-sov, V.A. Kokorin // Rossijskij kardiologicheskij zhur-nal. — 2001. — № 5. — S.88—94.